Listar por tema "pneumococcal conjugate vaccines"
Mostrando ítems 1-1 de 1
-
Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of age
(European Journal of Clinical Microbiology and Infectious Diseases, 2022)The major goals of the study were to describe the invasive pneumococcal disease (IPD) cases due to erythromycin-resistant serotypes and to evaluate the association between these cases and recent macrolide use in individuals ...